These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 33905818)
1. PD-1 signaling pathway in sepsis: Does it have a future? Chen R; Zhou L Clin Immunol; 2021 Aug; 229():108742. PubMed ID: 33905818 [TBL] [Abstract][Full Text] [Related]
2. [Progress in PD-1/PD-L1, PD-L2 signaling pathway and its role in host anti-tuberculosis immunity]. Yu XW; Zhang JA; Xie JP Zhonghua Jie He He Hu Xi Za Zhi; 2024 May; 47(5):485-489. PubMed ID: 38706074 [TBL] [Abstract][Full Text] [Related]
3. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246 [TBL] [Abstract][Full Text] [Related]
4. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis]. Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637 [No Abstract] [Full Text] [Related]
5. PD-1 as an immune modulatory receptor. Yao S; Chen L Cancer J; 2014; 20(4):262-4. PubMed ID: 25098286 [TBL] [Abstract][Full Text] [Related]
6. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680 [TBL] [Abstract][Full Text] [Related]
7. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Jiang Y; Chen M; Nie H; Yuan Y Hum Vaccin Immunother; 2019; 15(5):1111-1122. PubMed ID: 30888929 [TBL] [Abstract][Full Text] [Related]
8. [Role and application of programmed death protein 1 (PD-1) and its ligand PD-L1 in immune cell dysfunction in sepsis: An update]. Ding Y; Dai L; Xiang Y; Sun Y; Yu J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):843-848. PubMed ID: 32967768 [TBL] [Abstract][Full Text] [Related]
9. The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer. van Dam LS; de Zwart VM; Meyer-Wentrup FA Pediatr Blood Cancer; 2015 Feb; 62(2):190-197. PubMed ID: 25327979 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors. Liu M; Sun Q; Wei F; Ren X Cancer Biol Med; 2020 Aug; 17(3):626-639. PubMed ID: 32944395 [TBL] [Abstract][Full Text] [Related]
11. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis. Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977 [TBL] [Abstract][Full Text] [Related]
12. Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice. Li S; Tajiri K; Murakoshi N; Xu D; Yonebayashi S; Okabe Y; Yuan Z; Feng D; Inoue K; Aonuma K; Shimoda Y; Song Z; Mori H; Huang H; Aonuma K; Ieda M Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572655 [TBL] [Abstract][Full Text] [Related]
13. Biochemical signaling of PD-1 on T cells and its functional implications. Boussiotis VA; Chatterjee P; Li L Cancer J; 2014; 20(4):265-71. PubMed ID: 25098287 [TBL] [Abstract][Full Text] [Related]
14. An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal. Khedri M; Abnous K; Rafatpanah H; Ramezani M J Recept Signal Transduct Res; 2018 Feb; 38(1):31-36. PubMed ID: 29252078 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas. Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254 [TBL] [Abstract][Full Text] [Related]
16. Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. Huang X; Chen Y; Chung CS; Yuan Z; Monaghan SF; Wang F; Ayala A J Immunol; 2014 Feb; 192(3):1091-9. PubMed ID: 24379123 [TBL] [Abstract][Full Text] [Related]
17. New Insights into the Role of PD-1 and Its Ligands in Allergic Disease. Galván Morales MA; Montero-Vargas JM; Vizuet-de-Rueda JC; Teran LM Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769327 [TBL] [Abstract][Full Text] [Related]
18. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684 [TBL] [Abstract][Full Text] [Related]
19. HMGB1 promotes neutrophil PD-L1 expression through TLR2 and mediates T cell apoptosis leading to immunosuppression in sepsis. Liu J; Song K; Lin B; Chen Z; Zuo Z; Fang Y; He Q; Yao X; Liu Z; Huang Q; Guo X Int Immunopharmacol; 2024 May; 133():112130. PubMed ID: 38648712 [TBL] [Abstract][Full Text] [Related]
20. Expression of programmed death 1 ligands by murine T cells and APC. Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]